Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
6,101–6,120 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
AMZEAmaze Holdings, Inc.——$1.97M+557.8%-$55.17M$2.38M$5.99MAI pending
ANG-PDAmerican National Group Inc.——$7.49B-0.4%$533M$8.42B$2.96BAI pending
ANVIAnvi Global Holdings, Inc.——$137.91K—-$218.41K$390—AI pending
APGEApogee Therapeutics, Inc.—————$105.57M$6.83MFair valued
APTAlpha Pro Tech Ltd——$59.14M+2.3%$3.53M$18.9M$7.62MAI pending
APUSApimeds Pharmaceuticals US, Inc.—————$278.37K$9.07MAI pending
ARENArena Group Holdings, Inc.——$134.83M+7.1%$124.86M$11.17M$99.88MAI pending
ARKBArk 21Shares Bitcoin ETF—————$100—AI pending
ARMPArmata Pharmaceuticals, Inc.——$4.9M-5.2%-$173.8M$23.95M$30.45MAI pending
ASMAvino Silver & Gold Mines Ltd——$66.18M+50.8%$8.1M$57.33M$1.94MAI pending
ATCHAtlasClear Holdings, Inc.——$10.86M+171.3%$5.75M$16.71M$15.6MAI pending
ATCXATLAS CRITICAL MINERALS Corp——$92.49K-86.1%-$5.42M$30.22K—AI pending
ATH-PAAthene Holding Ltd.——$25.68B+24.1%$2.71B$23.71B$7.83BAI pending
ATMPBarclays Bank PLC——£9.71B+3.8%£4.66B£229.95B£622MAI pending
ATNMActinium Pharmaceuticals, Inc.——$90K+11.1%-$33.89M$36.47M$1.34MAI pending
AUSTAustin Gold Corp.—————$573.16K—AI pending
AWXAvalon Holdings Corp——$83.55M-0.3%$321K$4.8M$31.11MAI pending
AXILAxil Brands, Inc.——$30.85M+17.5%$2.7M$4.46M$404.67KAI pending
AZTRAzitra, Inc.——$0-100.0%-$10.96M$6.73M$410.05KAI pending
BARGraniteShares Gold Trust———————AI pending